Sunday, December 10, 2023
Village Voice News
ADVERTISEMENT
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us
No Result
View All Result
Village Voice News
No Result
View All Result
Home Global

New drug for Alzheimer’s expected this week

Admin by Admin
January 3, 2023
in Global
New Scientist Photo

New Scientist Photo

0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

READ ALSO

UN takes no immediate action at emergency meeting on Guyana-Venezuela dispute over oil-rich region

Senior officials pledge allegiance to Constitution

Support Village Voice News With a Donation of Your Choice.

The US Food and Drug Administration  (FDA) may likely  decide to grant accelerated approval to the experimental dementia drug named Lecanemab. The drug, manufactured by drug companies Eisai and Biogen, is one of the first medications that shows significant promise in the treatment of Alzheimer’s disease.
Eisai spokesperson Libby Holman confirmed that

“If lecanemab is approved by the FDA under the Accelerated Approval Pathway, Eisai will do its best to make lecanemab available as soon as possible,”

The American Alzheimer’s Disease Association expects the FDA to announce a decision by January 6.
Maria Carillo, the association’s science officer said, We believe, based on the totality of positive data from clinical trials of this treatment, that the FDA should approve. Peer-reviewed, published results show lecanemab will provide patients in the earliest stages of Alzheimer’s more time to participate in daily life and live independently. It could mean many months more of recognizing their spouse, children and grandchildren.”
Alzheimer’s disease is a form of dementia that usually starts with memory loss and gets worse over time. Brain cells die and the brain shrinks which leads to deficits in cognitive functions, such as memory, language skills, and behavior.
Guyana’s health minister Dr. Frank Anthony had spoken about the disease last September during Alzheimer’s Awareness Month.
 
The Minister said, “The estimate right now is that one in six persons between 80 and 85 years of age would have Alzheimer’s or dementia. One in three persons above 85 would have Alzheimer’s, and one in two above 90 would have Alzheimer’s, so age is really an important factor here.”
 
Minister Anthony spoke of the symptoms of the disease. He said, “What we need to look at is initially the disease would present with very subtle changes. So, people start losing their memory gradually, they are not remembering things, you might say something to them, they forget what you have just said to them, they repeat themselves, so they may tell you something now, repeat that a little, a few minutes, so they can’t remember what they have said to you.”
Dr. Anthony noted that, “It’s very important that if you find that an older relative or someone in your care is having these signs and symptoms, is for them to come to the hospital so that the doctors can make that diagnosis and probably advise on treatment and be able to give you better advice on how to care for these persons.”
 
Meanwhile, clinical trials of the drug indicate that there may be side effects The most common adverse events in the lecanemab group were reactions to the intravenous infusions and abnormalities on their MRIs, such as brain swelling and bleeding called amyloid-related imaging abnormalities, or ARIA, which can become life threatening.
Experts assure that even after the drug is approved, patients will be monitored and studies of the medication’s effects will continue. However, experts across the medical community report excitement and optimism regarding the drug’s potential benefits.



Support Village Voice News With a Donation of Your Choice



ShareTweetSendShareSend

Related Posts

National Assembly President Jorge Rodriguez, left, and Chairman of the Special Commission for the Defense of Guyana Essequibo Hermann Escarra, shake hands after unveiling Venezuela's new map that includes the Essequibo territory, a swath of land that is administered and controlled by Guyana but claimed by Venezuela, in Caracas, Venezuela, Friday, Dec. 8, 2023. (AP Photo/Matias Delacroix)
Global

UN takes no immediate action at emergency meeting on Guyana-Venezuela dispute over oil-rich region

by Admin
December 9, 2023

By Edith M. Lederer Associated Press UNITED NATIONS -- The United Nations Security Council took no immediate action at a closed...

Read more
Senior officials of departments and units under China's State Council make a public pledge of allegiance to the Constitution at a ceremony, which is overseen by Premier Li Qiang, on Dec. 8, 2023. (Xinhua/Liu Bin)
Global

Senior officials pledge allegiance to Constitution

by Admin
December 8, 2023

BEIJING, Dec. 8 (Xinhua) -- A total of 73 senior officials of 52 departments and units under China's State Council...

Read more
Xi Jinping, General Secretary of the Communist Party of China (CPC) Central Committee and Chinese president, attends the CPC meeting
Global

CPC leadership holds meeting on 2024 economic work, anti-corruption work, Party discipline

by Admin
December 8, 2023

BEIJING, Dec. 8 (Xinhua) -- The Political Bureau of the Communist Party of China (CPC) Central Committee on Friday held...

Read more
Next Post
Sulemana Abdul Samed aka Awuche

9 ft. 6in and still growing: The Ghanaian giant reported to be the world’s tallest man

EDITOR'S PICK

Govt to engage ECD squatters after fiery standoff with police

October 1, 2020

Region 10 shutdown received wide support

September 6, 2021
Trade unionist Lincoln Lewis

Violence erupting from protest must be placed at President Ali’s feet- Lewis

June 29, 2022
The Iranian supreme leader, Ayatollah Ali Khamenei, was one of the statesmen taking pleasure in a moment of superiority over the US. Photograph: AP

‘What a spectacle!’: US adversaries revel in post-election chaos

November 6, 2020

© 2022 Village Voice | Developed by Ink Creative Agency

No Result
View All Result
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us

© 2022 Village Voice | Developed by Ink Creative Agency